A COVID-19 patient often presents with multiple comorbidities and is associated with
adverse outcomes. A comprehensive assessment of the prevalence of comorbidities in …

Abstract Coronavirus disease 2019 (COVID-19) is an acute respiratory disease caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can lead to acute …

The prevalence of patients admitted to intensive care units (ICUs) with SARS-CoV-2
infection who were prescribed antibiotics is undetermined and might contribute to the …

A recently discovered coronavirus, SARS-CoV-2, caused a global respiratory disease
pandemic called COVID-19. Many studies have shown the excessive activation of the innate …

Background Colchicine was recently repurposed for the management of coronavirus
disease 2019 (COVID‐19). This rapid review and meta‐analysis aimed to assess …

Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is a matter of concern worldwide and a huge …

Coronavirus disease 2019 (COVID-19) had caused huge health losses worldwide. Several
drugs had been applied to treat patients with COVID-19, and repurposing colchicine had …

Cohort studies have shown that both overweight and obesity have their impact by increasing
hospitalization with COVID‐19. We conducted a systematic literature search in PubMed …

The COVID-19 pandemic has had significant impacts on healthcare systems around the
world, including in Latin America. In Colombia, there have been over 23,000 confirmed …

The impact of COVID-19 prompted a race to find a treatment that would reduce its mortality.
Most studies have not shown favorable results for many of these drugs, but they are still …